Hepatocellular carcinoma : Prospects for natural killer cell immunotherapy
© 2018 John Wiley & Sons Ltd. Published by John Wiley & Sons Ltd..
Liver disease is a growing cause of death in the United Kingdom and the incidence of hepatocellular carcinoma (HCC) is rising (http://www.cancerresearchuk.org/). The combination of an immunosuppressive environment within the liver and suboptimal host anti-tumour immune responses may account for the poor survival outcome of HCC. Understanding how tumours evade immune recognition coupled with new insights into the unique immunological environment within the liver will be critical to developing liver-specific immunotherapies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2018 |
|---|---|
| Enthalten in: |
HLA - (2018) vom: 17. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adoptive transfer |
|---|
| Anmerkungen: |
Date Revised 27.02.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1111/tan.13275 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM283156104 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM283156104 | ||
| 003 | DE-627 | ||
| 005 | 20240229161540.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/tan.13275 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1308.xml |
| 035 | |a (DE-627)NLM283156104 | ||
| 035 | |a (NLM)29667374 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kumar, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatocellular carcinoma |b Prospects for natural killer cell immunotherapy |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2018 John Wiley & Sons Ltd. Published by John Wiley & Sons Ltd. | ||
| 520 | |a Liver disease is a growing cause of death in the United Kingdom and the incidence of hepatocellular carcinoma (HCC) is rising (http://www.cancerresearchuk.org/). The combination of an immunosuppressive environment within the liver and suboptimal host anti-tumour immune responses may account for the poor survival outcome of HCC. Understanding how tumours evade immune recognition coupled with new insights into the unique immunological environment within the liver will be critical to developing liver-specific immunotherapies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a adoptive transfer | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a natural killer cells | |
| 700 | 1 | |a Khakoo, S I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t HLA |d 2016 |g (2018) vom: 17. Apr. |w (DE-627)NLM255931107 |x 2059-2310 |7 nnns |
| 773 | 1 | 8 | |g year:2018 |g day:17 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/tan.13275 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2018 |b 17 |c 04 | ||